Jingmin Zhao

9PUBLICATIONS
22CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTraditional Chinese medicine and treatmentsAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 22, 2025
Elevated HSP70 Ameliorates Liver Failure Patients via Its Novel Natural Inhibitor.

Yu Zhang, Lina Jiang, Yiyun Jiang

|Mar 14, 2024
An optimized short-term steroid therapy for chronic drug-induced liver injury: A prospective randomized clinical trial.

Ang Huang, Yun Zhu, Shuhong Liu

|Feb 06, 2024
Increased antibody titers but induced T cell AICD and apoptosis response in COVID-19 convalescents by inactivated vaccine booster.

Jingmin Zhao, Han Zhang, Lina Jiang

|Apr 01, 2022
Corticosteroid plus glycyrrhizin therapy for chronic drug- or herb-induced liver injury achieves biochemical and histological improvements: a randomised open-label trial.

Jia-Bo Wang, Ang Huang, Yijin Wang

|Jan 25, 2022
Diagnostic Value of Serum Golgi Protein 73 for Liver Inflammation in Patients with Autoimmune Hepatitis and Primary Biliary Cholangitis.

Mingjie Yao, Leijie Wang, Jianwen Wang

|Feb 25, 2020
Serum Golgi Protein 73 as a Potential Biomarker for Hepatic Necroinflammation in Population with Nonalcoholic Steatohepatitis.

Leijie Wang, Mingjie Yao, Shuhong Liu

Pageof 2

Frequent Collaborators

2 joint publications

Yijin Wang

2 joint publications

Mingjie Yao

2 joint publications

Fengmin Lu

2 joint publications

Zhengsheng Zou